The U.S. Supreme Court said April 21 it would block a lower court’s restrictions on an abortion pill, leaving the drug on the market while litigation over the drug proceeds.
Supreme Court blocks lower court’s restrictions on abortion pill, leaving drug on the market during litigation
Supreme Court temporarily blocks lower court rulings restricting abortion pills amid legal challenge
The U.S. Supreme Court said April 14 it would temporarily keep in place status quo federal regulations regarding the use of an abortion drug, giving the court additional time to consider a lower court’s ruling to stay the U.S. Food and Drug Administration’s approval of the drug.
Federal judge’s pending ruling could block abortion drug from nationwide sale
A lawsuit by a coalition of pro-life opponents of the drug mifepristone, the first of two drugs used in a medication or chemical abortion, is demanding the U.S. Food and Drug Administration revoke its approval of the drug.
Wyoming becomes first state to ban abortion pills
The state’s legislature passed two pieces of legislation in March that would restrict abortion in the state, but the governor allowed the other bill to become law without his signature.
Pro-life groups, members of Congress weigh in on chemical abortion case
Four medical associations and four doctors filed suit in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration over the FDA’s approval of the use of chemical abortion drugs which they say present adverse health and safety risks to women who use them.
New abortion pill rules challenge Catholics to reimagine effective pro-life outreach
The FDA announced early January that under its modified Mifepristone REMS Program, patients will be able to acquire Mifeprex — and its approved generic — at retail pharmacies.
FDA decision on medical abortion puts women’s lives, health at risk, says bishops’ pro-life chair
By no longer requiring the abortion drug mifepristone to be picked up in person, the U.S. Food and Drug Administration is “merely succumbing to the abortion industry’s pressure to loosen safety standards,” instead of protecting the lives and health of mothers and children as it should do, he said.